BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9922003)

  • 1. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
    Metze K; Trevisan MA
    Cancer; 1999 Jan; 85(1):250. PubMed ID: 9922003
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
    Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
    Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review.
    Henderson DW; Shilkin KB; Whitaker D
    Am J Clin Pathol; 1998 Sep; 110(3):397-404. PubMed ID: 9728617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Utility of morphometry and nucleolar organizer regions count in the differentiation of reactive and malignant mesothelial cells in pleural effusions].
    Colecchia M; Agnelli T; Caronni E; Leopardi O
    Pathologica; 1991; 83(1083):89-97. PubMed ID: 1866205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation.
    Soosay GN; Griffiths M; Papadaki L; Happerfield L; Bobrow L
    J Pathol; 1991 Apr; 163(4):299-305. PubMed ID: 2033489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of nucleoli and nucleolar organizer regions in cultured primary human normal, reactive and malignant mesothelial cells.
    Ribotta M; Donna A; Betta PG; Libener R; Bellingeri D; Robutti F
    Pathol Res Pract; 1992 Jun; 188(4-5):536-40. PubMed ID: 1409084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions.
    Derenzini M; Nardi F; Farabegoli F; Ottinetti A; Roncaroli F; Bussolati G
    Acta Cytol; 1989; 33(4):491-8. PubMed ID: 2473585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of malignant from normal and reactive mesothelial cells by the argyrophil technique for nucleolar organiser region associated proteins.
    Ayres JG; Crocker JG; Skilbeck NQ
    Thorax; 1988 May; 43(5):366-70. PubMed ID: 2461601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-automatic quantitation of nucleolar organizer regions in non-Hodgkin's lymphomas.
    Kalir T; Chan KS; Liu Z; Strauchen J; Gil J
    Pathol Res Pract; 1994 Feb; 190(2):124-8. PubMed ID: 7520162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of silver staining-nucleolar organizer regions (Ag-NOR) in nasopharyngeal carcinoma].
    Dai W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(1):43-4, 62. PubMed ID: 1317196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of argyrophilic proteins in the nucleolar organizer regions of human thymocytes and thymic epitheliocytes under conditions of coculturing with vilon and epithalon peptides.
    Raikhlin NT; Bukaeva IA; Smirnova EA; Yarilin AA; Sharova NI; Mitneva MM; Khavinson VKh; Polyakova VO; Trofimov AV; Kvetnoi IM
    Bull Exp Biol Med; 2004 Jun; 137(6):588-91. PubMed ID: 15455093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports.
    King J; Thatcher N; Pickering C; Hasleton P
    Histopathology; 2006 Dec; 49(6):561-8. PubMed ID: 17163840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative study on nucleolar organizer regions in salivary gland tumours].
    Wang SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Mar; 27(2):74-6, 127. PubMed ID: 1337733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silver staining of nucleolus organizer regions (NORs). Application to the study of nucleolar structure and value in pathology].
    Ploton D; Menager M; Lechki C; Jeannesson P; Visseaux B; Adnet JJ
    Ann Pathol; 1988; 8(3):248-52. PubMed ID: 2460107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
    Cheville JC; Clamon GH; Robinson RA
    Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids.
    Colecchia M; Leopardi O
    Pathol Res Pract; 1992 Jun; 188(4-5):541-4. PubMed ID: 1409085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.
    Marshall RJ; Herbert A; Braye SG; Jones DB
    J Clin Pathol; 1984 Nov; 37(11):1215-21. PubMed ID: 6094617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nucleolar organizer regions in uterine cervical cancer and its precursor epithelial lesions].
    Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Rojo J
    Rev Med Chil; 1993 Oct; 121(10):1110-7. PubMed ID: 8191113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.